BlackRock »

Sage Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Sage Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sage Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sage Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $39M 5.4M 7.22

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Sage Therapeutics

Vanguard Group
BlackRock
BlackRock
Bellevue Group
State Street Corporation
Jacobs Levy Equity Management
Morgan Stanley
Geode Capital Management
Palo Alto Investors
Acadian Asset Management
Goldman Sachs Group
Federated Investors
Citadel Advisors
Renaissance Technologies
T. Rowe Price Associates

View all funds holding Sage Therapeutics